FIELD: chemistry.
SUBSTANCE: invention relates to compounds of general formulae
,
or ,
wherein X represents halogen or oxo; Q represents -C(O)H, -CH=CHC(O)OY1, -C(R)H(CH2)nOY1 or -C(R)HCH2C(O)OY1; R represents H; n equals 1 or 2; Y1, Y3 and Y4, each independently represents H or protective group for hydroxyl; T represents oxo or -OY5; and Y5 represents H or protective group for hydroxyl or Y5, together with oxygen atom, which it is bound with, represents leaving group, wherein protective group for hydroxyl Y1 and Y5, together with oxygen atom, which each of them is bound with, independently represents C1-C12 alprotective group for hydroxyl, and protective group for hydroxylkyl- or carbocyclic C6-C20 aryl- ester Y3 and Y4, together with oxygen atom, which each of them is bound to, independently represents tri(C1-C6alkyl)silyl or- di(C6-C10aryl)(C1-C6alkyl)silyl- ether protective group for hydroxyl, and leaving group represents (C1-C12)alkylsulphonate or carbocyclic (C6-C20)arylsulphonate, which are used to obtain chalichondrin B analogues for synthesis, such as eribulin and its pharmaceutically acceptable salts.
EFFECT: invention also relates to methods for obtaining ER-804028 and eribulin or its pharmaceutically acceptable salt, for instance eribulin mesilate.
28 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
MACROCYCLIZATION REACTIONS AND INTERMEDIATE COMPOUNDS AND OTHER FRAGMENTS SUITABLE FOR PREPARING ANALOGUES OF HALICHONDRIN B | 2014 |
|
RU2710545C2 |
NOVEL COMPOUNDS FOR DIAGNOSING, TREATING AND PREVENTING DISEASES ASSOCIATED WITH ALPHA-SYNUCLEIN AGGREGATION | 2020 |
|
RU2822486C1 |
ANTHELMINTHIC DEPSIPEPTIDE COMPOUNDS | 2016 |
|
RU2707298C2 |
PRINCE REACTION AND INTERMEDIATE PRODUCTS USED IN SYNTHESIS OF HALICHONDRIN MACROLIDES AND THEIR ANALOGUES | 2017 |
|
RU2777913C2 |
HERBICIDAL SUBSTITUTED PYRIMIDINYLOXYBENZOLE COMPOUNDS | 2014 |
|
RU2703460C1 |
FLUOROALKYLATING AGENT | 2015 |
|
RU2716008C2 |
BRUTON'S TYROSINE KINASE INHIBITORS | 2010 |
|
RU2542585C2 |
FLUOROPHENYL-BETA-HYDROXYETHYLAMINES AND THEIR USE FOR THE TREATMENT OF HYPERGLYCEMIA | 2018 |
|
RU2801096C2 |
BORONIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE | 2017 |
|
RU2773346C2 |
NOVEL DERIVATIVES OF BENZIMIDAZOLE AND THEIR USING AS MEDICAMENTS | 2002 |
|
RU2294326C2 |
Authors
Dates
2016-04-10—Published
2011-01-26—Filed